NMVB News

2018 NMVB Face-to-Face Conference

The yearly NMVB Face-to-Face Conference kicked off on June 7, 2018 at the University of Pittsburgh by Michael J. Becich, MD, PhD. Attendance included Roswell Park Cancer Institute (Dr. Gaudioso), NYU Langone Medical Center (Dr. Pass), University of Maryland (Dr. Melamed), University of Pennsylvania (Dr. Feldman), University of Pittsburgh (Dr. Becich), Centers for Disease Control and Prevention (Joan Karr), and UMPC (Julie Ward) representatives. The group discussed everything from the previous years’ statistics to the NMVB’s tissue sample collection to future research and publications.

 

The meeting, held from 8:30 am until 2:30 pm, discussed the differences in epithelioid subtype morphologies and malignant pleural mesothelioma interactome discovery analysis. Dr. Doug Hartman drew on the importance of having consistent naming across the multiple types of peritoneal tissue morphologies. Madhavi Ganapathiraju gave examples of her forthcoming publication on her research in Interactome Discovery Analysis. They both gained important insight into where their research could continue to grow using NMVB.

 

The meeting concluded with several facts and figures about the general use of the NMVB database and the characteristics of the data already collected. This data included demographic, geographic, and occupational information and analysis to show the importance of survey collection along with tissue sample collection.

 

For more information about the presentations given, please visit the Presentation Archives.

NMVB Funded for five years

The National Mesothelioma Virtual Bank (NMVB) consents patients to provide biospecimens (blood products and tissue) together with demographic data, occupational history and clinical data (stage, treatment and survival information) to the mesothelioma research community.  The University of Pittsburgh (Pitt) is the coordinating site, and the NMVB protocol is in place at three partnering sites, New York University, Roswell Park Cancer Institute and University of Pennsylvania. Our specific aims are to: 1) Continue to serve the mesothelioma cancer research community by collecting and distributing tissue, blood and the aforementioned data as well as increasing the NMVB cohort to 2400 patients. We will continue to document and continually evaluate the usefulness of the NMVB to the scientific community and measure its impact in collaboration with the Mesothelioma Applied Research Foundation; 2) Expand the NMVB to the University of Maryland as a site and add fresh frozen tissue and blood product collection at Roswell Park Cancer Institute.; and 3) Automate annotation of biospecimens through extraction of clinical, outcomes, and pathology data from electronic health records and cancer registry systems.  We have successfully deployed and implemented a scalable informatics solution to maximize the effectiveness of the data extraction process across collaborating sites which will allow linkage to other national tissue and data sharing networks.    Link to NIH RePORT Page